Effects of Reduced Follicle-stimulating Hormone Dosage Before Human Chorionic Gonadotropin Trigger on in Vitro Fertilization Outcomes

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2023 Aug 25

PMID 37626299

Authors

Zhanhui Ou

Jing Du

Nengqing Liu

Jieliang Li

Xiufeng Lin

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether a reduced dose of follicle-stimulating hormone (FSH) before human chorionic gonadotropin (hCG) trigger during ovarian stimulation can affect in vitro fertilization (IVF) outcomes.

Methods: This study included 347 patients with a normal ovarian response who received a reduced dose of FSH before hCG trigger for 2-3 days (Group A) and 671 patients who did not receive a reduced dose (Group B) from a university-affiliated IVF center between January 2021 and December 2022. The primary endpoint was estrogen (E2) and progesterone (P) levels on the day of hCG trigger, fresh embryo transfer cycles, laboratory outcomes, and clinical outcomes between the two groups.

Results: On the day of hCG trigger, Group A had significantly lower E2 and P levels than those in Group B (3454.95 ± 1708.14 pg/mL versus 3798.70 ± 1774.26 pg/mL, p = 0.003; and 1.23 ± 0.53 ng/mL versus 1.37 ± 0.59 ng/mL, p < 0.001, respectively). The proportion of patients with P levels ≥ 1.5 ng/mL was 22.48% in Group A compared to 34.58% in Group B (p < 0.001), while the proportion of patients with E2 ≥ 5000 pg/mL was 15.27% in Group A compared to 25.93% in Group B (p < 0.001). The fresh embryo-transfer cycle rate in Group A was higher than that in group B (54.47% and 32.64%, respectively; p < 0.001). Despite the reduction in FSH dosage, there were no significant differences between groups regarding the number of oocytes retrieved, total number of mature oocytes, normal fertilization rate, cleavage rate, Day 3 top-quality rate, implantation rate, pregnancy rate per cycle, and early pregnancy loss rate.

Conclusion: While a reduced dose of FSH prior to hCG trigger during ovarian stimulation did not significantly affect IVF outcomes, it was associated with lower E2 and P levels, resulting in fewer cycles with E2 ≥ 5000 pg/mL and P ≥ 1.5 ng/mL on the day of the hCG trigger.

References

Van Vaerenbergh I, Fatemi H, Blockeel C, Van Lommel L, Int Veld P, Schuit F . Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online. 2011; 22(3):263-71. DOI: 10.1016/j.rbmo.2010.11.002. View

Wang A, Santistevan A, Hunter Cohn K, Copperman A, Nulsen J, Miller B . Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates. Fertil Steril. 2017; 108(2):254-261.e4. DOI: 10.1016/j.fertnstert.2017.05.007. View

Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S . Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005; 84(3):555-69. DOI: 10.1016/j.fertnstert.2005.02.053. View

Koundouros S . A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization. Fertil Steril. 2007; 90(3):569-75. DOI: 10.1016/j.fertnstert.2007.06.080. View

Aboulghar M . Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod. 2003; 18(6):1140-1. DOI: 10.1093/humrep/deg208. View

Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S . Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective.... Fertil Steril. 2011; 95(6):2029-33, 2033.e1. DOI: 10.1016/j.fertnstert.2011.01.163. View

Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson G . Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril. 2013; 101(1):128-33. DOI: 10.1016/j.fertnstert.2013.09.025. View

Alviggi C, Andersen C, Buehler K, Conforti A, De Placido G, Esteves S . A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016; 105(6):1452-3. DOI: 10.1016/j.fertnstert.2016.02.005. View

Martinez F, Rodriguez I, Devesa M, Buxaderas R, Gomez M, Coroleu B . Should progesterone on the human chorionic gonadotropin day still be measured?. Fertil Steril. 2015; 105(1):86-92. DOI: 10.1016/j.fertnstert.2015.09.008. View

10.

Venetis C, Kolibianakis E, Bosdou J, Lainas G, Sfontouris I, Tarlatzis B . Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015; 30(3):684-91. DOI: 10.1093/humrep/deu362. View

11.

Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J . Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010; 25(8):2092-100. DOI: 10.1093/humrep/deq125. View

12.

Erickson G, Wang C, Hsueh A . FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature. 1979; 279(5711):336-8. DOI: 10.1038/279336a0. View

13.

Labarta E, Martinez-Conejero J, Alama P, Horcajadas J, Pellicer A, Simon C . Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011; 26(7):1813-25. DOI: 10.1093/humrep/der126. View

14.

Garcia-Velasco J, Isaza V, Quea G, Pellicer A . Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?. Fertil Steril. 2006; 85(3):547-54. DOI: 10.1016/j.fertnstert.2005.07.1335. View

15.

Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A . Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002; 78(5):1025-9. DOI: 10.1016/s0015-0282(02)03323-x. View

16.

Zhen X, Qiao J, Li R, Wang L, Liu P . The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples. J Assist Reprod Genet. 2008; 25(1):17-22. PMC: 2582105. DOI: 10.1007/s10815-007-9187-9. View

17.

Nyboe Andersen A, Witjes H, Gordon K, Mannaerts B . Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011; 26(12):3413-23. DOI: 10.1093/humrep/der318. View

18.

DAngelo A, Amso N, Hassan R . Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2017; 5:CD002811. PMC: 6481358. DOI: 10.1002/14651858.CD002811.pub4. View

19.

Lawrenz B, Beligotti F, Engelmann N, Gates D, Fatemi H . Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod. 2016; 31(11):2554-2560. DOI: 10.1093/humrep/dew213. View

20.

Ubaldi F, Bourgain C, Tournaye H, Smitz J, VAN Steirteghem A, Devroey P . Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997; 67(3):521-6. DOI: 10.1016/s0015-0282(97)80080-5. View